Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)

Jin, YH; Zeng, XT; Liu, TZ; Bai, ZM; Dou, ZL; Ding, DG; Fan, ZL; Han, P; Huang, YR; Huang, X; Li, M; Li, XD; Li, YN; Li, XH; Liang, CZ; Liu, JM; Ma, HS; Qi, J; Shi, JQ; Wang, J; Wang, DL; Wang, ZP; Wang, YY; Wang, YB; Wei, Q; Xia, HB; Xing, JC; Yan, SY; Zhang, XP; Zheng, GY; Xing, NZ; He, DL; Wang, XH

Wang, XH (通讯作者),Wuhan Univ, Zhongnan Hosp, Ctr Evidence Based & Translat Med, Wuhan 430071, Peoples R China.;Wang, XH (通讯作者),Wuhan Univ, Zhongnan Hosp, Inst Urol, Dept Urol, Wuhan 430071, Peoples R China.;Xing, NZ (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Urol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China.;He, DL (通讯作者),Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Urol, Xian 710061, Peoples R China.

MILITARY MEDICAL RESEARCH, 2022; 9 (1):

Abstract

Non-muscle invasive bladder cancer (NMIBC) is a major type of bladder cancer with a high incidence worldwide, resulting in a great disease burden. Tre......

Full Text Link